BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 16223604)

  • 1. Gene therapy restores vision-dependent behavior as well as retinal structure and function in a mouse model of RPE65 Leber congenital amaurosis.
    Pang JJ; Chang B; Kumar A; Nusinowitz S; Noorwez SM; Li J; Rani A; Foster TC; Chiodo VA; Doyle T; Li H; Malhotra R; Teusner JT; McDowell JH; Min SH; Li Q; Kaushal S; Hauswirth WW
    Mol Ther; 2006 Mar; 13(3):565-72. PubMed ID: 16223604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal degeneration 12 (rd12): a new, spontaneously arising mouse model for human Leber congenital amaurosis (LCA).
    Pang JJ; Chang B; Hawes NL; Hurd RE; Davisson MT; Li J; Noorwez SM; Malhotra R; McDowell JH; Kaushal S; Hauswirth WW; Nusinowitz S; Thompson DA; Heckenlively JR
    Mol Vis; 2005 Feb; 11():152-62. PubMed ID: 15765048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapeutic prospects in early onset of severe retinal dystrophy: restoration of vision in RPE65 Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.
    Rolling F; Le Meur G; Stieger K; Smith AJ; Weber M; Deschamps JY; Nivard D; Mendes-Madeira A; Provost N; Péréon Y; Cherel Y; Ali RR; Hamel C; Moullier P; Rolling F
    Bull Mem Acad R Med Belg; 2006; 161(10-12):497-508; discussion 508-9. PubMed ID: 17503728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electroretinographic analyses of Rpe65-mutant rd12 mice: developing an in vivo bioassay for human gene therapy trials of Leber congenital amaurosis.
    Roman AJ; Boye SL; Aleman TS; Pang JJ; McDowell JH; Boye SE; Cideciyan AV; Jacobson SG; Hauswirth WW
    Mol Vis; 2007 Sep; 13():1701-10. PubMed ID: 17960108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency.
    Pang J; Boye SE; Lei B; Boye SL; Everhart D; Ryals R; Umino Y; Rohrer B; Alexander J; Li J; Dai X; Li Q; Chang B; Barlow R; Hauswirth WW
    Gene Ther; 2010 Jul; 17(7):815-26. PubMed ID: 20237510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis.
    Jacobson SG; Boye SL; Aleman TS; Conlon TJ; Zeiss CJ; Roman AJ; Cideciyan AV; Schwartz SB; Komaromy AM; Doobrajh M; Cheung AY; Sumaroka A; Pearce-Kelling SE; Aguirre GD; Kaushal S; Maguire AM; Flotte TR; Hauswirth WW
    Hum Gene Ther; 2006 Aug; 17(8):845-58. PubMed ID: 16942444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle.
    Redmond TM; Yu S; Lee E; Bok D; Hamasaki D; Chen N; Goletz P; Ma JX; Crouch RK; Pfeifer K
    Nat Genet; 1998 Dec; 20(4):344-51. PubMed ID: 9843205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.
    Le Meur G; Stieger K; Smith AJ; Weber M; Deschamps JY; Nivard D; Mendes-Madeira A; Provost N; Péréon Y; Cherel Y; Ali RR; Hamel C; Moullier P; Rolling F
    Gene Ther; 2007 Feb; 14(4):292-303. PubMed ID: 17024105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy rescues cone structure and function in the 3-month-old rd12 mouse: a model for midcourse RPE65 leber congenital amaurosis.
    Li X; Li W; Dai X; Kong F; Zheng Q; Zhou X; Lü F; Chang B; Rohrer B; Hauswirth WW; Qu J; Pang JJ
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):7-15. PubMed ID: 21169527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent phenotypes of vision and accessory visual function in mice with visual cycle dysfunction (Rpe65 rd12) or retinal degeneration (rd/rd).
    Thompson S; Mullins RF; Philp AR; Stone EM; Mrosovsky N
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2737-42. PubMed ID: 18515598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New views on RPE65 deficiency: the rod system is the source of vision in a mouse model of Leber congenital amaurosis.
    Seeliger MW; Grimm C; Ståhlberg F; Friedburg C; Jaissle G; Zrenner E; Guo H; Remé CE; Humphries P; Hofmann F; Biel M; Fariss RN; Redmond TM; Wenzel A
    Nat Genet; 2001 Sep; 29(1):70-4. PubMed ID: 11528395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentiviral gene transfer of RPE65 rescues survival and function of cones in a mouse model of Leber congenital amaurosis.
    Bemelmans AP; Kostic C; Crippa SV; Hauswirth WW; Lem J; Munier FL; Seeliger MW; Wenzel A; Arsenijevic Y
    PLoS Med; 2006 Oct; 3(10):e347. PubMed ID: 17032058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal disease in Rpe65-deficient mice: comparison to human leber congenital amaurosis due to RPE65 mutations.
    Caruso RC; Aleman TS; Cideciyan AV; Roman AJ; Sumaroka A; Mullins CL; Boye SL; Hauswirth WW; Jacobson SG
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5304-13. PubMed ID: 20484585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal chromophore injections delay early-onset and rapid retinal cone degeneration in a mouse model of Leber congenital amaurosis.
    Dai X; Jin X; Ye Q; Huang H; Duo L; Lu C; Bao J; Chen H
    Exp Eye Res; 2021 Nov; 212():108776. PubMed ID: 34582935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection.
    Jacobson SG; Acland GM; Aguirre GD; Aleman TS; Schwartz SB; Cideciyan AV; Zeiss CJ; Komaromy AM; Kaushal S; Roman AJ; Windsor EA; Sumaroka A; Pearce-Kelling SE; Conlon TJ; Chiodo VA; Boye SL; Flotte TR; Maguire AM; Bennett J; Hauswirth WW
    Mol Ther; 2006 Jun; 13(6):1074-84. PubMed ID: 16644289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye.
    Li W; Kong F; Li X; Dai X; Liu X; Zheng Q; Wu R; Zhou X; Lü F; Chang B; Li Q; Hauswirth WW; Qu J; Pang JJ
    Mol Vis; 2009; 15():267-75. PubMed ID: 19190735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. R91W mutation in Rpe65 leads to milder early-onset retinal dystrophy due to the generation of low levels of 11-cis-retinal.
    Samardzija M; von Lintig J; Tanimoto N; Oberhauser V; Thiersch M; Remé CE; Seeliger M; Grimm C; Wenzel A
    Hum Mol Genet; 2008 Jan; 17(2):281-92. PubMed ID: 17933883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous activity of opsin apoprotein is a cause of Leber congenital amaurosis.
    Woodruff ML; Wang Z; Chung HY; Redmond TM; Fain GL; Lem J
    Nat Genet; 2003 Oct; 35(2):158-64. PubMed ID: 14517541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal human ocular degeneration occurs in Leber's congenital amaurosis (LCA2).
    Porto FB; Perrault I; Hicks D; Rozet JM; Hanoteau N; Hanein S; Kaplan J; Sahel JA
    J Gene Med; 2002; 4(4):390-6. PubMed ID: 12124981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of the transcription factor Mef2c during retinal degeneration in Rpe65-/- mice.
    Escher P; Schorderet DF; Cottet S
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5933-40. PubMed ID: 21715356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.